SAMANTHA DAVIS: Open Payments
NPI 1801231931 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 22 payments from 7 companies in 2025. Trend: 2023 $156 · 2024 $436 · 2025 $600
Food & beverage: $557Education: $43
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $248 |
| Eisai Inc. | 7 | $192 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Janssen Biotech, Inc. | 2 | $40 |
| Corcept Therapeutics | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| ConvaTec Inc. | 1 | $20 |
Products named: Lenvima, KEYTRUDA, LYNPARZA, ENHERTU, ERLEADA, Korlym, ORGOVYX, KEYTRUDA QLEX.
Industry payments across IN — which companies pay providers there.
